DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000MG09PC2

Real-time Bid/Ask 05:53:51 2024-06-05 EDT
0.068 EUR / 0.083 EUR +7.04% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-33.64%
1 month-40.83%
Date Price Change
24-06-05 0.068 -4.23%
24-06-04 0.071 -18.39%
24-06-03 0.087 -18.69%
24-05-31 0.107 +5.94%
24-05-30 0.101 -8.18%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 04:57 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG09PC
ISINDE000MG09PC2
Date issued 2024-03-15
Strike 115 $
Maturity 2024-09-20 (108 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.242
Lowest since issue 0.06
Spread 0.02
Spread %23.26%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
71.42 USD
Average target price
90.29 USD
Spread / Average Target
+26.42%
Consensus